THE CALIBER GROUP RETAINED BY ROCHE PHARMACEUTICAL CANCER DIAGNOSTIC DIVISION

April 24, 2020

Ariz. (April 23, 2018) — The Caliber Group announces new client Roche Molecular Solutions, a division of Roche, the world’s largest biotech company. Caliber will provide support on digital and social media campaigns, website development, competitive intelligence and other projects targeted to niche audiences in the global B2B space to increase sales of Roche’s instruments and assays.

← Back to Newsroom